TrialDrugs in R&D2025

A Bioequivalence Study of Recombinant Human Follicle-Stimulating Hormone Injection Versus Recombinant Human Follitropin For Injection in Healthy Chinese Adult Women.

Jigang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.